Literature DB >> 22913153

The relationships between clinical outcome and the levels of total antioxidant capacity (TAC) and coenzyme Q (CoQ 10) in children with pandemic influenza (H 1 N1) and seasonal flu.

S Kelekçi1, O Evliyaoğlu, V Sen, I Yolbaş, U Uluca, I Tan, M F Gürkan.   

Abstract

BACKGROUND AND AIM: This study was planned to evaluate the relationships between the levels of total antioxidant capacity (TAC) and Coenzyme Q (CoQ10) and clinical outcome in hospitalized children with pandemic influenza (H1N1). Serum copper (Cu) and zinc (Zn) levels were also determined to evaluate the changings of oxidative stress's enzyme activities depending on their cofactor concentrations. PATIENTS AND METHODS: Children with suspected H1N1 virus infection were hospitalized and nasal swabs were sent to laboratory for confirmation of H1N1 by rRT-PCR assay. Age and sex matched 31 healthy children were included as Control Group. Total antioxidant capacity and CoQ10 were determined by spectrophotometry and HPLC, respectively, and Cu and Zn were determined using atomic absorption spectrometer.
RESULTS: Totally 28 children had H1N1 and 37 children had seasonal influenza (SI). TAC, CoQ10 and Zn levels were found to be significantly decreased in H1N1 patients (1.01 +/- 0.19, 752.2 +/- 163, 69 +/- 27, respectively) compared to Control Group (1.64 +/- 0.36, 934 +/- 21, 92 +/- 4, respectively). Seasonal Influenza group had significantly decreased TAC and Zn levels (1.31 +/- 0.27, 78 +/- 34 respectively) compared with control group (1.64 +/- 0.36, 92 +/-41, respectively). CoQ10 levels were also found as decreased in H1N1 compared to seasonal influenza (752.2 +/- 163 vs 1022 +/- 199, p = 0.003). There was a significant correlation between CoQ10 levels of sera and chest radiographic findings of patients with H1N1 pneumonia. No significant differences were found in serum Cu levels between patients with H1N1 and SI or control group (150 +/- 45 vs 127 +/- 37, p = 0.215). CONCLUSIONS, Pandemic influenza infection had increased oxidative stress compared to the seasonal influenza.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913153

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  COVID-19, Coenzyme Q10 and Selenium.

Authors:  I R Hargreaves; D Mantle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  A Green Antioxidant Activity-Integrated Dual-Standard Method for Rapid Evaluation of the Quality of Traditional Chinese Medicine Xuebijing Injection by On-Line DPPH-CE-DAD.

Authors:  Jin Li; Jiao Liu; Wei Liu; Xie-An Yu; Jun Cao; Mingrui An; Xiu-Mei Gao; Yan-Xu Chang
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-31       Impact factor: 2.629

3.  Coenzyme Q10 in acute influenza.

Authors:  Maureen Chase; Michael N Cocchi; Xiaowen Liu; Lars W Andersen; Mathias J Holmberg; Michael W Donnino
Journal:  Influenza Other Respir Viruses       Date:  2018-09-30       Impact factor: 4.380

Review 4.  Coenzyme Q10 and Immune Function: An Overview.

Authors:  David Mantle; Robert A Heaton; Iain P Hargreaves
Journal:  Antioxidants (Basel)       Date:  2021-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.